Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand

Lam Research Corporation (LRCX) is up 7.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to Lam’s latest quarterly results coming in strong and management issuing an upbeat outlook for the next quarter, reinforcing expectations that chipmakers are sustaining higher spending on leading-edge and AI-related capacity. A better-than-feared forward view on revenue and profitability likely drove a reassessment of near-term earnings power.

Details:

Lam reported March-quarter revenue of $5.84 billion and non-GAAP EPS of $1.47, alongside operating margin expansion versus the prior quarter.

For the quarter ending June 28, 2026, Lam guided revenue to $6.60 billion plus or minus $400 million, implying another step up in demand for its wafer-fab equipment and services.

Management highlighted AI-driven industry demand and positioned the company as benefiting from increasing device complexity, which can translate into higher intensity of etch and deposition steps.

The company also noted meaningful cash deployment for capital return activities during the quarter, which can support sentiment when paired with rising earnings expectations.

Sources:

Lam Research Investor Relations, U.S. Securities and Exchange Commission, The Motley Fool

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$LRCX Insider Trading Activity

$LRCX insiders have traded $LRCX stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $LRCX stock by insiders over the last 6 months:

TIMOTHY ARCHER (President and CEO) has made 0 purchases and 2 sales selling 163,300 shares for an estimated $26,758,338.
DOUGLAS R BETTINGER (Chief Financial Officer & EVP) has made 0 purchases and 3 sales selling 130,466 shares for an estimated $26,534,860.
ERIC BRANDT has made 0 purchases and 2 sales selling 35,000 shares for an estimated $7,896,150.
NEIL J FERNANDES (Senior Vice President) sold 18,170 shares for an estimated $4,635,893
AVA HARTER (Chief Legal Officer) has made 0 purchases and 3 sales selling 11,510 shares for an estimated $2,818,536.
BETHANY MAYER sold 30 shares for an estimated $4,785

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$LRCX Hedge Fund Activity

We have seen 1,130 institutional investors add shares of $LRCX stock to their portfolio, and 1,107 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 38,239,309 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $6,545,804,914
PRICE T ROWE ASSOCIATES INC /MD/ added 10,666,540 shares (+352.2%) to their portfolio in Q4 2025, for an estimated $1,825,898,317
BLACKROCK, INC. added 10,000,727 shares (+8.0%) to their portfolio in Q4 2025, for an estimated $1,711,924,447
JPMORGAN CHASE & CO removed 6,436,253 shares (-21.5%) from their portfolio in Q4 2025, for an estimated $1,101,757,788
NORDEA INVESTMENT MANAGEMENT AB removed 3,909,309 shares (-34.6%) from their portfolio in Q4 2025, for an estimated $669,195,514
FRANKLIN RESOURCES INC added 3,671,073 shares (+57.0%) to their portfolio in Q4 2025, for an estimated $628,414,276
CORIENT PRIVATE WEALTH LLC added 3,649,553 shares (+235.5%) to their portfolio in Q4 2025, for an estimated $624,730,482

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$LRCX Congressional Stock Trading

Members of Congress have traded $LRCX stock 9 times in the past 6 months. Of those trades, 3 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $LRCX stock by members of Congress over the last 6 months:

REPRESENTATIVE DAVID TAYLOR has traded it 6 times. They made 1 purchase worth up to $15,000 on 03/12 and 5 sales worth up to $145,000 on 02/26, 01/16, 01/08.
REPRESENTATIVE CLEO FIELDS purchased up to $50,000 on 02/03.
SENATOR JOHN BOOZMAN sold up to $15,000 on 01/08.
SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 12/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

$LRCX Analyst Ratings

Wall Street analysts have issued reports on $LRCX in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 01/29/2026
Goldman Sachs issued a "Buy" rating on 01/29/2026
RBC Capital issued a "Outperform" rating on 01/15/2026
Wells Fargo issued a "Overweight" rating on 01/15/2026
Bernstein issued a "Outperform" rating on 01/12/2026
Mizuho issued a "Outperform" rating on 01/09/2026
B. Riley Securities issued a "Buy" rating on 12/18/2025

To track analyst ratings and price targets for $LRCX, check out Quiver Quantitative's $LRCX forecast page.

$LRCX Price Targets

Multiple analysts have issued price targets for $LRCX recently. We have seen 21 analysts offer price targets for $LRCX in the last 6 months, with a median target of $300.0.

Here are some recent targets:

Jay Goldberg from Seaport Global set a target price of $300.0 on 05/05/2026
Tom O'Malley from Barclays set a target price of $275.0 on 04/23/2026
Charles Shi from Needham set a target price of $300.0 on 04/23/2026
C.J. Muse from Cantor Fitzgerald set a target price of $320.0 on 04/23/2026
Atif Malik from Citigroup set a target price of $315.0 on 04/23/2026
Brian Chin from Stifel set a target price of $325.0 on 04/23/2026
Vivek Arya from B of A Securities set a target price of $330.0 on 04/23/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.